European Medicines Agency’s data protection notice for the EudraVigilance Signal and Safety Analytics (EV SSA) platform

Questions and answers on the use of Product Lifecycle Management (PLCM) document - Scientific guideline

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR): Austedo, deutetrabenazine, Date of authorisation: 08/01/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Nexviadyme, avalglucosidase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Travatan, travoprost, Date of authorisation: 27/11/2001, Revision: 32, Status: Authorised

European Medicines Agency’s data protection notice for EudraVigilance Human (EV)

Joint controllership arrangement with regard to EudraVigilance Human (EV)

SMS guidance for external users

PRAC work plan 2026